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Abstract
The transient receptor potential melastatin type 8 (TRPM8) receptor channel is
expressed in primary afferent neurons where it is the main transducer of innocuous
cold temperatures and also in a variety of tumors, where it is involved in progression
and metastasis. Modulation of this channel by intracellular signaling pathways has
therefore important clinical implications. We investigated the modulation of
recombinant and natively expressed TRPM8 by the Src kinase, which is known to
be involved in cancer pathophysiology and inflammation. Human TRPM8 expressed in
HEK293T cells is constitutively tyrosine phosphorylated by Src which is expressed
either heterologously or endogenously. Src action on TRPM8 potentiates its activity,
as treatment with PP2, a selective Src kinase inhibitor, reduces both TRPM8 tyrosine
phosphorylation and cold‐induced channel activation. RNA interference directed
against the Src kinase diminished the extent of PP2‐induced functional down-
regulation of TRPM8, confirming that PP2 acts mainly through Src inhibition. Finally,
the effect of PP2 on TRPM8 cold activation was reproduced in cultured rat dorsal
root ganglion neurons, and this action was antagonized by the protein tyrosine
phosphatase inhibitor pervanadate, confirming that TRPM8 activity is sensitive to the
cellular balance between tyrosine kinases and phosphatases. This positive modulation
of TRPM8 by Src kinase may be relevant for inflammatory pain and cancer signaling.
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1 | INTRODUCTION
Mammals possess 28 subtypes of transient receptor potential (TRP)
channels, eight of which belong to the melastatin subgroup (TRPM) and
are responsible for a variety of cellular functions (Mickle, Shepherd, &
Mohapatra, 2015). TRPM8 is a temperature‐gated ion channel found in
the peripheral nervous system (PNS), but also in non‐neuronal tissue,
such as the prostate (Babes, Ciobanu, Neacsu, & Babes, 2011). It is
activated by a decrease in ambient temperature, natural compounds
(menthol, eucalyptol, camphor) or synthetic ligands (icilin, WS12; Bödding
Wissenbach, & Flockerzi, 2007) and modulated by changes in membrane
potential (Fernández et al., 2011). One of the main physiological functions
of TRPM8 is to detect innocuous cold, and genetic deletion of this
channel interferes with normal temperature preference behavior
(Bautista et al., 2007). Inflammation and nerve injury are associated
with enhanced cold sensitivity, and TRPM8 contributes to these
alterations in temperature sensing (Knowlton, Bifolck‐Fisher, Bautista,
& McKemy, 2010; Dhaka et al., 2007).
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TRPM8 is expressed in a variety of cancer types including breast,
prostate, lung, and colon, but it is also expressed in nonmalignant
tissues (Hantute‐Ghesquier, Haustrate, Prevarskaya, & Lehen’kyi,
2018; Yudin & Rohacs, 2012). At subcellular level, TRPM8 is
expressed both in the endoplasmic reticulum and plasma membrane
of LNCaP prostate cancer epithelial cells (Noyer, Grolez, Prevars-
kaya, Gkika, & Lemonnier, 2018). Plasma membrane localization has
been linked to a higher apoptosis rate and cancer progression was
associated with channel internalization through ubiquitination
(Asuthkar, Demirkhanyan, Mueting, Cohen, & Zakharian, 2017;
Asuthkar, Velpula, Elustondo, Demirkhanyan, & Zakharian, 2015).
The initial article on TRPM8 reported its upregulation in prostate
cancer and in primary tumors of breast, colon, lung and skin origin
(Tsavaler, Shapero, Morkowski, & Laus, 2001). However, according to
later reports, its role can be either stimulatory in cell proliferation of
prostate, breast or pancreatic cells or inhibitory in migration of
prostate cancer cells or in the proliferation of melanoma cells (Cucu
et al., 2014; Hantute‐Ghesquier et al., 2018).
Apart from its role in cold sensing, TRPM8 plays an essential role
both in physiological and in pathological processes like endothelial cell
motility, extracellular matrix degradation, proliferation, oxidative stress
or protein unfolding (Noyer et al., 2018). Thus, it is expected to be under
strict control of regulatory mechanisms. Indeed, it has been shown that
the channel activity of the purified protein requires the presence of
phosphoinositides and inorganic polyphosphate (Zakharian, Thyagarajan,
French, Pavlov, & Rohacs, 2009). Testosterone also associates with
TRPM8, acting as a potent agonist of the channel (Asuthkar et al., 2015).
Activity of TRPM8 is also regulated by two short splice variants of the
channel, sM8α and sM8β, which generate proteins sM8‐6 and sM8–18.
The sM8‐6 isoform downregulates TRPM8 activity by interacting with
the C‐terminus of the receptor and inducing through allosteric
modulation the closed state of the channel (Fernández et al., 2012).
It has been evidenced since long that protein phosphorylation may
significantly contribute to the modulation of ion channels’ activity.
Thus, Ser/Thr protein kinases such as PKC, PKA, or Tyr kinases like
Src‐kinase can regulate the activity of numerous thermo‐TRPs. For
example, a number of Ser and Thr residues on TRPV1 were identified
as phosphorylation targets of protein kinases, though only some of
them were found as modulators of the temperature‐sensitive ion
current (Huang, Zhang, & McNaughton, 2006). Ser/Thr phosphoryla-
tion of TRPM8 has also been reported. Thus, it has been shown that
activation of PKC by phorbol esters leads to reduced serine‐
phosphorylation and functional downregulation of TRPM8. These
effects are attributable to PKC‐mediated activation of Ser/Thr
phosphatases like PP2A (Premkumar et al., 2005). The regulatory
effect of tyrosine phosphorylation on the TRPV subfamily has been
intensively studied. Thus, it was shown that Src‐mediated phosphor-
ylation of TRPV1 at Tyr200 leads to modulation of subcellular
trafficking of TRPV1 to the plasma membrane (X. Zhang, Huang, &
McNaughton, 2005). On the other hand protein tyrosine phosphatase
(PTP) Shp‐1 dephosporylates TRPV1 in dorsal root ganglion (DRG)
neurons and reduces the inflammatory pain in rats, induced by
Complete Freund’s adjuvant (Xiao et al., 2015). Similarly, TRPV4
phosphorylation by Src family kinases, in different cell lines has been
reported. Two novel phosphorylation sites in the cytosolic N‐ and C‐
terminal tails of TRPV4 were identified. The N‐terminal tyrosine plays
a crucial role in the activation of TRPV4 by heat, mechanical
stress, hypotonic cell swelling, and phorbol 12‐myristate 13‐acetate
(Wegierski, Lewandrowski, Müller, Sickmann, & Walz, 2009).
The number of reports on the modulatory role of tyrosine
phosphorylation on members of the TRPM subclass is limited.
TRPM2 tyrosine phosphorylation was demonstrated and it was
found that tyrosine phosphorylation is important in TRPM2 activa-
tion and function (W. Zhang et al., 2007). As concerning TRPM8, it
was shown that PP2 (a selective Src family tyrosine kinase inhibitor)
inhibited, in a dose‐dependent manner, the agonist‐induced
responses of TRPM8 expressed in SH‐SY5Y cells (Morgan, Sadofsky,
Crow, & Morice, 2014). However, it is still unclear which tyrosine
kinase mediates phosphorylation and how phosphorylation modu-
lates cold‐induced responses in cell lines expressing TRPM8, as well
as in cultured neurons. We report here that TRPM8 is tyrosine
phosphorylated by Src and partly by TrkA kinases. Our results show
that pervanadate (PV) treatment stimulates while PP2 treatment
prevents phosphorylation of TRPM8 in cells expressing TRPM8. We
also provide evidence that inhibition of endogenous Src kinase
diminishes both phosphorylation and cold‐induced activation of
TRPM8. In cultured rat DRG neurons PP2 and dasatinib (another
Src kinase inhibitor) were found to downregulate TRPM8‐mediated
responses, effect which was antagonized by PV.
2 | MATERIALS AND METHODS
2.1 | Cell culture and transfection procedures
Human embryonic kidney 293T (HEK293T) cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM), supplemented with
10% fetal bovine serum, 1× non‐essential amino acids and 1× sodium
pyruvate (all from Thermo Fisher Scientific). For biochemical
experiments, we used human TRPM8 (UniProt Q7Z2W7) with an
N‐terminus VSV‐G tag (sequence YTDIEMNRLGK; VSV‐G‐TRPM8).
cDNAs coding for VSV‐G‐TRPM8, a constitutively active form of Src
(SrcY527F), Abl, Btk, and TrkA protein tyrosine kinases were
introduced into HEK293T cells by polyethylenimine (PEI; Sigma)
transfection (DNA:PEI 1:3). Cells were transfected at 60–70%
confluency with 8 μg of VSV‐G‐TRPM8 DNA/25 cm2 flask. In VSV‐
G‐TRPM8/tyrosine kinase co‐expression experiments cells were
transfected with a total of 8 μg of DNA/25 cm2 flask (6 μg of VSV‐
G‐TRPM8 DNA and 2 μg DNA for tyrosine kinases). Cells were
harvested after 48 hr of transfection. For calcium microfluorimetry
recordings we used HEK293 cells stably expressing human TRPM8
(HEK293‐hTRPM8 cells) maintained in DMEM F12 medium supple-
mented with 10% fetal bovine serum, 1% penicillin/streptomycin, 1%
L‐glutamine and 1mg/ml G418 (all from Sigma). HEK293‐hTRPM8
cells were transfected at 60–70% confluency with 0.6 μg of SrcY527F
DNA/35mm dish using Jet‐PEI (Polyplus; DNA:Jet‐PEI 1:2.5).
Calcium microfluorimetry recordings were performed 48 hr after
2
ht
tp
://
do
c.
re
ro
.c
h
transfection. For Src kinase silencing, HEK293‐hTRPM8 cells were
transfected with Silencer® Select Pre‐Designed & Validated siRNA
(Ambion/Thermo Fisher Scientific) and Silencer® Select Negative
Control #1 siRNA (scrambled RNA; the producer company refuse to
disclose the sequence of the Silencer Select negative control) was
used as control. siRNA was generated against the human Src
sequence 5′‐GCCTCTCAGTGTCTGACTT‐3′. Cells were transfected
at 30–40% confluency with 10 nM siRNA or Scrambled RNA, using
Lipofectamine RNAiMax (Invitrogen). After 96 hr, cells were either
used for calcium microfluorimetry recordings or were harvested for
biochemical experiments.
2.2 | Cell treatment
For biochemical experiments, cells transfected with VSV‐G‐TRPM8
were treated with 1mM PV, a protein tyrosine phosphatase inhibitor.
Cells were incubated with PV in complete DMEM medium for 15min
and then harvested. HEK293T cells cotransfected with VSV‐G‐
TRPM8 and SrcY527F were incubated with 10 μM PP2 (Sigma) in
complete DMEM medium for the indicated times.
2.3 | Cell lysis and BCA assay
All cells were washed with ice‐cold phosphate‐buffered saline and
then harvested in ice‐cold 50mM Tris Base pH 7.4, 150mM NaCl,
10mM MgCl2, 10% glycerol and 1% Nonidet‐P40 (1% Nonidet‐P40
lysis buffer) supplemented with 1X protease inhibitor cocktail (Santa
Cruz Biotechnology Inc), 1 mM phenylmethylsulfonyl fluoride, 1 mM
orthovanadate and 5mM iodacetic acid. The cells were passed
through a needle 10 times then kept on ice for 20min. Cell lysates
were clarified by centrifugation (20,000g, 30 min, 4°C). To determine
total protein concentration, we used the BCA assay (Bicinchoninic
acid assay; Thermo Fisher Scientific). Briefly, a volume of 10 μl of cell
lysate was incubated with 200 μl working reagent (reagentA:rea-
gentB 50:1) for 30min at 37°C and then the sample absorbances
were read at 480 nm. Lysate samples were diluted in 2.5× sodium
dodecyl sulfate (SDS)‐gel loading buffer, boiled for 5min at 70°C and
then used for western blot assay to verify protein expression.
2.4 | Immunoprecipitation
VSV‐G‐TRPM8 was immunoprecipitated from the lysate supernatant
using a mouse monoclonal VSV‐G antibody (Santa Cruz Biotechnology
Inc.; sc365019). Lysate supernatants were incubated for 1 hr at 4°C
with the VSV‐G antibody followed by overnight incubation with protein
G‐Sepharose beads (Sigma). Protein G‐Sepharose beads were washed
and equilibrated in 1% nonidet‐P40 lysis buffer. The immunoprecipi-
tates were washed three times with ice‐cold lysis buffer, diluted in 1×
SDS‐gel loading buffer, boiled for 5min at 70°C and used for western
blot assay to verify VSV‐G‐TRPM8 tyrosine phosphorylation.
2.5 | Western blot analysis
Proteins from cell lysates were separated by SDS‐polyacrylamide gel
electrophoresis on a 10% polyacrylamide gel and immunoprecipitated
samples were separated on a 7.5% polyacrylamide gel. Proteins were
transferred to polyvinylidene fluoride membranes and the blots were
blocked for 40min in 5% milk (Sigma) or 10% BSA (Santa Cruz
Biotechnology Inc) diluted in Tris‐buffered saline with 0.1% Tween‐20
(TBS‐T) 1× and incubated with primary antibodies for 1 hr at room
temperature. The blots were washed three times at 10min interval in
TBS‐T 1× and were incubated with the secondary antibodies for 1 hr at
room temperature. Western blot analysis Luminol Reagent (Santa Cruz
Biotechnology Inc) was used to detect the proteins of interest by
exposure on an X‐ray film.
2.6 | Antibodies and reagents
VSV‐G‐TRPM8 expression was detected with the mouse monoclonal
VSV‐G antibody used for immunoprecipitation. Src expression
(SrcY527F and c‐src) was detected with a mouse monoclonal Src
antibody (Millipore; MABS193, clone327) and the phosphorylation of
tyrosine 418 was detected by the rabbit polyclonal Src (phospho418)
antibody (Abcam; ab4816). Abl and Btk tyrosine kinases had a flag tag
(DYKDDDDK sequence) and were detected using a mouse monoclonal
flag M2 antibody (Sigma; F1804). TrkA tyrosine kinase was detected
using a rabbit polyclonal TrkA antibody (Alomone Labs; ANT‐018). Actin
was detected by a mouse monoclonal actin antibody (BD Bioscience; cat
#612657). Tyrosine‐phosphorylated VSV‐G‐TRPM8 was detected by the
mouse monoclonal antibody pTyr(pY99)‐HRP (Santa Cruz Biotechnology
Inc; sc‐7020) that recognizes phosphotyrosine.
2.7 | Rat DRG culture
Adult male Wistar rats (150–200 g; n = 9) from the Institute of
Cellular Biology and Pathology “Nicolae Simionescu”, Bucharest,
Romania were used. Animal handling procedures were performed in
accordance with the EU Directive 2010/63/EU revising Directive 86/
609/EEC concerning the protection of animals used for research
purposes and were approved by the Bioethics Committee of the
Faculty of Biology, University of Bucharest. The rats were euthanized
by inhalation of 100% CO2 for 2min and then decapitated. DRGs
from T12‐S1 spinal segments were dissected out and placed in 2mg/
ml collagenase (from Clostridium histolyticum, type XI; Sigma) and
3mg/ml dispase (Gibco) for 1 hr at 37°C in IncMix solution (155mM
NaCl, 1.5 mM K2HPO4, 5.6 mM 4‐(2‐hydroxyethyl)‐1‐piperazineetha-
nesulfonic acid [HEPES], 4.8 mM Na‐HEPES, 5mM glucose, adjusted
to pH 7.4 with NaOH). Following incubation, DRG neurons were
mechanically dissociated, plated on 25‐mm glass coverslips which
had been coated with poly‐D‐lysine (0.1 mg/ml; Sigma) for 30min and
cultured in DMEM F12 medium supplemented with 10% horse serum
(Sigma) and gentamicin (50 μg/ml; Sigma) at 37°C and 5% CO2.
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2.8 | Intracellular nonratiometric calcium
microfluorimetry (used with HEK293 cells and rat
DRG neurons)
HEK293‐hTRPM8 cells and DRG neurons cultured on 25mm glass
coverslips were maintained in standard ECS (see Section 2.9) containing
2 μM Calcium Green‐1 AM and 0.02% Pluronic F‐127 (both from
Invitrogen) for 30min at 37°C and allowed 30min to recover before use.
Coverslips were mounted in a Teflon chamber (MSC TD, Digitimer,
Welwyn Garden, UK) on the stage of an Olympus IX70 inverted
microscope. Temperature stimuli were applied through local superfusion
using a Peltier‐based system (Reid, Amuzescu, Zech, & Flonta, 2001). We
also used a miniature thermocouple (1T‐1E, Physitemp, Clifton, NJ)
placed very close to the cells to measure in real time the temperature
experienced by the imaged cells during the experiment. For HEK293‐
hTRPM8 cells, cold ramps (from ∼32°C to ∼25°C, 45 s duration) were
applied at 5min interval, in the presence and in the absence of 10 μM
PP2. For DRG neurons, similar cold ramps were applied at 10min
interval, in the presence and in the absence of 10 μM PP2, 1 μM
dasatinib, 1mM PV or a mixture of PP2 and PV/dasatinib and PV. We
also applied (−)‐menthol (200 μM) at the end of the experiment, to select
only TRPM8+ cells and 50mM KCl to identify viable neurons.
Fluorescence changes were recorded with a CCD camera (Cohu 4910;
Pieper GmbH, Schwerte, Germany). Cells were illuminated at 470nm
with a Dual OptoLED light source (Cairn Research, Faversham, UK)
controlled by the Axon Imaging Workbench 2.2 software (Axon
Instruments, Union, CA), which was also used for image acquisition and
analysis. The change in the calcium indicator fluorescence was analyzed
with custom software and the maximal fluorescence change during
stimulation relative to the initial fluorescence (ΔF/F0, or “amplitude”) was
measured. A value of ΔF/F0 > 0.1 was considered a response.
2.9 | Solutions
Standard extracellular solution (ECS) contained 140mM NaCl, 4 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, 10mM HEPES, 4.54mM NaOH and
5mM glucose, pH 7.4 at 25°C. Drugs were added from the following
stock solutions: 10mM PP2 (Sigma) in dimethyl sulphoxide (DMSO),
10mM dasatinib (Sigma) in DMSO, PV (mixture of 250mM Na3VO4
and 35% H2O2), 200mM menthol in ethanol, KCl (standard
extracellular solution containing 50mM KCl). The stock solutions
were kept at 4°C or −20°C and diluted to the desired final
concentration in ECS.
2.10 | Data analysis
All calcium microfluorimetry data were analyzed in OriginPro 8.0
(OriginLab). Results are presented as means ± SEM or F/F0 ratio.
Statistical analysis was performed with two‐tailed unpaired Student’s
t test or one‐way analysis of variance (ANOVA). For the quantifica-
tion of VSV‐G‐TRPM8 tyrosine phosphorylation we used ImageJ.
3 | RESULTS
3.1 | TRPM8 is tyrosine phosphorylated by Src
kinase and partly by TrkA
To investigate tyrosine phosphorylation of TRPM8 we initially
evaluated the effect of PV, a nonspecific inhibitor of PTPs, on cells
transfected with human TRPM8 (hTRPM8). Thus, HEK293T cells
transiently transfected with VSV‐G‐tagged hTRPM8 were treated
with 1mM PV for 15min and VSV‐G‐TRPM8 was immunoprecipi-
tated with an anti‐VSV‐G antibody. Western blot analysis with anti‐
pTyr‐HRP antibody revealed substantial tyrosine phosphorylation of
the TRPM8 channel after PV treatment (Figure 1a). The next step
was to identify protein tyrosine kinases (PTKs) involved in tyrosine
phosphorylation of hTRPM8. To this aim four human PTKs were
tested: three representatives of soluble PTK subclasses (Src, Abl, and
Btk) and one representative of receptor PTKs (TrkA). HEK293T cells
were cotransfected with VSV‐G‐TRPM8 and one of the mentioned
protein tyrosine kinases (Figure 1). VSV‐G‐TRPM8 was immunopre-
cipitated with the anti‐VSV‐G antibody and analyzed by western blot
using anti‐pTyr‐HRP antibody. The strong band detected at
~140 kDa indicates that TRPM8 is tyrosine phosphorylated in the
presence of SrcY527F (Figure 1a). Moderate tyrosine phosphoryla-
tion of TRPM8 can also be observed when TrkA kinase is
overexpressed (Figure 1b), while Abl and Btk overexpression lead
to phosphorylation only to a minor extent (Figure 1a).
To further elucidate whether tyrosine phosphorylation of TRPM8
is due to the action of Src, we used PP2. HEK293T cells
cotransfected with VSV‐G‐TRPM8 and SrcY527F were treated with
10 μM PP2 for 2, 4, 8 and 24 hr, respectively (Figure 2a). Because
PP2 was solubilized in DMSO, we have also treated the cells with
DMSO for 24 hr to control for a possible effect of DMSO on TRPM8
tyrosine phosphorylation. A significant inhibition of TRPM8 tyrosine
phosphorylation can be observed after 2 or 4 hr of PP2 treatment, as
well as a complete elimination of tyrosine phosphorylation following
8 hr of PP2 application, compared with the two controls (untreated
cells or cells treated with DMSO for 24 hr), where strong
phosphorylation occurs (Figure 2a). After 24 hr of PP2 treatment, a
slight phosphorylated band was detected at ~140 kDa, possibly due
to PP2 degradation. To summarize these results, values of TRPM8
phosphorylation normalized to VSV‐G‐TRPM8 expression were
represented at different incubation time points (Figure 2b). These
results indicate that TRPM8 is tyrosine phosphorylated by Src, as
treatment of TRPM8‐expressing cells with PP2, an Src‐specific
inhibitor, prevents TRPM8 phosphorylation.
3.2 | Cold‐induced activation of TRPM8 is
antagonized by inhibition of Src kinase in cells stably
expressing hTRPM8
Tyrosine phosphorylation of a channel still does not guarantee any
modulatory effect of phosphorylation on the channel activity. Thus,
because cooling is the main physiological activator of TRPM8, we
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next investigated whether Src kinase is able to modulate cold‐
induced calcium transients mediated by hTRPM8 stably expressed in
HEK293 cells. The HEK293‐hTRPM8 cells were also transiently
transfected with the constitutively active SrcY527F kinase. Cold
ramps (from ∼32°C to ∼25°C, 45 s duration) were applied six times at
5min interval (Figures 3a and 3b) in the presence and in the absence
of 10 μM PP2. Cold‐induced activation of TRPM8 was progressively
inhibited by PP2 (Figures 3a and 3b): the ratio between the
amplitudes of the 6th and the 1st cold‐induced calcium transients
was 0.58 ± 0.01 (n = 437) in PP2‐treated cells compared with
0.93 ± 0.01 (n = 414) in control conditions (two‐tailed unpaired
Student’s t test, p < .0001; Figure 3c).
HEK293 cells express endogenous Src kinase. Therefore, the
above results cumulate the effect of PP2 inhibition on transfected
SrcY527F kinase as well as of endogenous Src. To assess the
contribution of endogenous Src to these results we repeated the
experiment under the same conditions in untransfected‐Src HEK293‐
hTRPM8 cells. A similar effect, but of smaller magnitude was observed
in HEK293‐hTRPM8 cells expressing endogenous Src. Acute applica-
tion of PP2 after the first cold ramp produced a decrease in the
TRPM8‐mediated response to cold ramps (Figures 4a and 4b): the
ratio between the amplitudes of the 6th and the 1st cold‐induced
calcium transients was 0.80 ± 0.01 (n = 319) in PP2‐treated cells
compared with 1.07 ± 0.01 (n = 329) in control conditions (two‐tailed
unpaired Student’s t test, p < .0001; Figure 4c). These calcium imaging
experiments demonstrate a relatively fast action of PP2, which is able
to produce significant TRPM8 inhibition within 10min. To confirm this
observation, we tried shorter PP2 treatments (5, 10, 20, and 30min) in
HEK293T cells cotransfected with VSV‐G‐TRPM8 and SrcY527F or
transfected with VSV‐G‐TRPM8 alone. The bands detected at
~135 kDa show that VSV‐G‐TRPM8 tyrosine phosphorylation was
progressively reduced with increasing PP2 treatment duration in
HEK293T cells cotransfected with VSV‐G‐TRPM8 and SrcY527F
(~63 kDa; Figure 3d and 3e). Importantly, VSV‐G‐TRPM8 was
constitutively tyrosine phosphorylated by the endogenous Src protein
kinase (c‐Src, ~63 kDa) in HEK293T cells transfected with VSV‐G‐
TRPM8 alone and PP2 treatment antagonized this action (Figure 4d
and 4e). We also checked the phosphorylation of Src kinase at tyrosine
418 (Tyr 416 on chicken Src), an important residue for the kinase
activity. We observed that both SrcY527F and c‐Src are phosphory-
lated at Tyr418 (~63 kDa; Figures 3d and 4d), that PP2 partly inhibits
the phosphorylation of Tyr418 in HEK293T cells cotransfected with
VSV‐G‐TRPM8 and SrcY527F (Figure 3d). The results described above
show that inhibition of Src‐mediated tyrosine phosphorylation
suppresses cold‐activation of TRPM8 in HEK293 cells stably expres-
sing TRPM8.
3.3 | Cold‐induced activation of TRPM8 is reduced
by RNA interference against endogenous Src kinase
in cells stably expressing TRPM8
The previous findings suggest that the inhibitory effect of PP2 on the
cold activation of recombinant human TRPM8 could be attributed at
least in part to its inhibition of endogenous Src. To further investigate
whether the PP2‐induced reduction of TRPM8‐mediated cold
responses might be caused by the inhibition of Src kinase, we
F IGURE 1 TRPM8 is tyrosine phosphorylated after pervanadate treatment, by Src protein tyrosine kinase and partly by TrkA protein
tyrosine kinase. (a) Western blot analysis of immunoprecipitated VSV‐G‐TRPM8 from VSV‐G‐TRPM8 cells treated with pervanadate or VSV‐G‐
TRPM8 + SrcY527F/Abl/Btk cells, demonstrating TRPM8 tyrosine phosphorylation (~140 kDa; top). Western blot analysis of VSV‐G‐TRPM8
alone or VSV‐G‐TRPM8 + SrcY527F/Abl/Btk cell lysates, to demonstrate protein expression after 48 hr of transfection (bottom). The
experiments were performed three times and representative data are shown. (b) Western blot analysis of immunoprecipitated VSV‐G‐TRPM8
from VSV‐G‐TRPM8 cells and VSV‐G‐TRPM8 + TrkA cells, demonstrating TRPM8 tyrosine phosphorylation (~135 kDa; top). Western blot
analysis of VSV‐G‐TRPM8 alone and VSV‐G‐TRPM8 + TrkA cell lysates, to demonstrate protein expression after 48 hr of transfection (bottom).
The experiments were performed two times and representative data are shown. TRPM8, transient receptor potential melastatin type 8
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silenced Src expression in HEK293‐hTRPM8 cells using short‐
interfering RNA against Src kinase (Src_siRNA). We then monitored
the effect of PP2 on cold‐induced calcium transients in cells
transfected with Src_siRNA compared with cells transfected with
scrambled RNA. Src kinase protein expression was reduced in
Src_siRNA‐transfected cells, compared with control untransfected
cells or scrambled RNA‐transfected cells (Figures 5a and 5b). The
bands detected at ~63 kDa show that Src kinase is phosphorylated at
Tyr418 in control cells and RNA‐trasfected cells, demonstrating the
kinase activity (Figure 5a). Cold ramps (from ∼32°C to ∼25°C, 45 s
duration) were applied seven times at 5 min interval (Figure 5c), in
the presence and in the absence of 10 μM PP2 (acutely applied after
the second cold stimulus). The initial response to cold stimulation was
significantly reduced in Src‐siRNA‐transfected cells, compared with
those transfected with scrambled RNA (0.61 ± 0.01, n = 680, com-
pared with 0.66 ± 0.01, n = 725, two‐tailed unpaired Student’s t test,
p < .0001). Tachyphylaxis of cold‐induced calcium transients occurred
in the presence of PP2 in HEK293‐hTRPM8 cells transfected with
both Src_siRNA and scrambled RNA, but the effect was more
pronounced in scrambled RNA‐transfected cells (Figure 5c).
In Src_siRNA‐transfected cells there was a reduction in the ratio
between the amplitudes of the 7th and the 1st cold‐induced calcium
transients of ca. 19% between control (1.12 ± 0.02, n = 345) and PP2‐
treated cells (0.91 ± 0.01, n =335). In scrambled RNA‐transfected cells,
the reduction in amplitude ratio (7th to 1st cold response) was
substantially larger (27%, from 1.00 ± 0.01, n = 389, to 0.73 ± 0.01,
n= 336; one‐way ANOVA with independent samples, p< .0001; Figure
5d). This experiment shows that by silencing endogenous Src the PP2‐
induced inhibition of thermal activation of TRPM8 is significantly
reduced.
3.4 | PP2‐induced inhibition of TRPM8 channel
activity in cultured rat DRG neurons is reduced in the
presence of PV
We investigated whether the stimulatory effect of tyrosine
phosphorylation on TRPM8 channel activity, which we observed
in HEK293‐hTRPM8 cells, also occurs in rat DRG neurons. To
address this question, we carried out calcium microfluorimetry
experiments on rat DRG neurons in primary culture, in which both
TRPM8 and Src kinase are natively expressed. Cold ramps (from
∼32°C to ∼25°C, 45 s duration), followed by menthol application
were used to activate native TRPM8, while PP2 (10 μM) and PV
(1 mM) were used to inhibit Src kinase and PTPs, respectively. We
only used for analysis cold‐sensitive neurons which also responded
to menthol, indicating expression of TRPM8 channels. There was no
difference in terms of cold sensitivity or tachyphylaxis of the cold
response between control neurons and those treated with PV, and
therefore we pooled these cells together in our analysis. PP2‐
induced tachyphylaxis of cold‐induced calcium transients was
significantly less pronounced in the presence of PV, than in the
absence of the PTP inhibitor (Figure 6a). The ratio between the
amplitudes of the 2nd and 1st calcium transients was 0.82 ± 0.05
(n = 21) in the presence of both PP2 and PV, compared with
0.60 ± 0.06 (n = 26) in the presence of PP2 only (two‐tailed unpaired
Student’s t test, p < .01). In control conditions (untreated neurons
and neurons treated with PV), the same ratio was 1.05 ± 0.04
(n = 45), significantly different compared with PP2‐treated neurons
(two‐tailed unpaired Student’s t test, p < .0001) and PV+PP2‐
treated neurons (two‐tailed unpaired Student’s t test, p < .001;
Figure 6b). For the third cold response, the effect of PP2 alone was
still significant compared with control (the 3rd to 1st response ratio
was 0.64 ± 0.07, n = 26 for PP2‐treated cells, compared with
0.97 ± 0.06, n = 45, for control cells, two‐tailed unpaired Student’s
t test, p < .001). Application of PP2 in the presence of PV diminished
the tachyphylaxis: the 3rd to 1st response ratio was 0.81 ± 0.06,
n = 21, not significantly different from PP2‐treated or control cells.
Thus, TRPM8‐mediated calcium transients in cultured rat DRG
neurons are inhibited by PP2 treatment of the cells, an effect that is
antagonized by inhibition of PTPs.
F IGURE 2 PP2 treatment prevents Src‐induced TRPM8 tyrosine
phosphorylation. (a) Western blot analysis of immunoprecipitated VSV‐
G‐TRPM8 from cells co‐expressing VSV‐G‐TRPM8 and SrcY527F,
untreated or treated with DMSO for 24 hr or with 10 μM PP2 for 2, 4,
8 and 24 hr respectively, showing TRPM8 tyrosine phosphorylation
(~140 kDa; top). Western blot assay using anti‐VSV‐G, anti‐Src, and
anti‐actin antibodies, to verify protein expression (bottom). (b) Relative
quantification of TRPM8 tyrosine phosphorylation normalized to VSV‐
G‐TRPM8 expression. Data are presented as pVSV‐G‐TRPM8/VSV‐G‐
TRPM8 mean ± SEM. DMSO, dimethyl sulphoxide; TRPM8, transient
receptor potential melastatin type 8
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F IGURE 3 Pharmacological inhibition of Src tyrosine kinase suppresses phosphorylation and cold‐induced activation of TRPM8 in HEK293‐
hTRPM8 cells transiently transfected with SrcY527F kinase. (a) Illustrative examples of traces from individual cells showing cold‐induced
calcium transients, in the presence (upper trace) and in the absence of PP2 (middle trace). A temperature recording during the stimulation
protocol consisting in six successive cold ramps is also shown (bottom trace). (b) Mean ΔF/F0 of cold‐induced calcium transients in control
conditions (black, n = 414) and during PP2 (10 μM) application (red, n = 437). Data are presented as ΔF/F0 mean ± SEM. (c) Comparison of the
ratio between the amplitudes of the 6th and the 1st cold‐induced calcium transients in cells treated with PP2 (red) or in control conditions
(black) for the experiment illustrated in A (****p < .0001, two‐tailed unpaired Student’s t test). (d) Western blot analysis of immunoprecipitated
VSV‐G‐TRPM8 from cells co‐expressing VSV‐G‐TRPM8 and SrcY527F, untreated or treated with PP2 10 μM for 5, 10, 20, and 30min
respectively, showing TRPM8 tyrosine phosphorylation (~135 kDa; top). Western blot assay, with anti‐VSV‐G, anti‐Src (phospho418), anti‐Src
and anti‐actin antibodies to demonstrate protein expression and the phosphorylation of SrcY527F kinase at tyrosine 418 (bottom). (e) Relative
quantification of TRPM8 tyrosine phosphorylation normalized in respect to VSV‐G‐TRPM8 immunoprecipitated from HEK293T cells co‐
expressing VSV‐G‐TRPM8 and SrcY527F. Data are presented as pVSV‐G‐TRPM8/VSV‐G‐TRPM8 mean ± SEM. TRPM8, transient receptor
potential melastatin type 8
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F IGURE 4 Pharmacological inhibition of endogenous Src tyrosine kinase suppresses phosphorylation and cold‐induced activation of TRPM8.
(a) Illustrative examples of traces from individual cells showing cold‐induced calcium transients, in the presence (upper trace) and in the absence
of PP2 (middle trace). A temperature recording during the stimulation protocol consisting in six successive cold ramps is also shown (bottom
trace). (b) Mean ΔF/F0 of cold‐induced calcium transients in control conditions (black, n = 329) and during PP2 (10 μM) application (red, n = 319).
Data are presented as ΔF/F0 mean ± SEM. (c) Comparison of the ratio between the amplitudes of the 6th and the 1st cold‐induced calcium
transients in cells treated with PP2 (red) or in control conditions (black) for the experiment illustrated in A (****p < .0001, two‐tailed unpaired
Student’s t test). (d) Western blot analysis of immunoprecipitated VSV‐G‐TRPM8 from cells expressing VSV‐G‐TRPM8, untreated or treated
with PP2 10 μM for 5, 10, 20, and 30min, respectively, showing TRPM8 tyrosine phosphorylation (~140 kDa; top). Western blot assay, with
anti‐VSV‐G, anti‐Src, and anti‐actin antibodies to demonstrate the protein expression (middle). Western blot assay, with anti‐Src (phospho418),
anti‐Src and anti‐actin antibodies to demonstrate the phosphorylation of endogenous Src kinase at tyrosine 418 (bottom). (e) Relative
quantification of TRPM8 tyrosine phosphorylation normalized to VSV‐G‐TRPM8 immunoprecipitated from HEK293T cells expressing VSV‐G‐
TRPM8 and endogenous Src. Data are presented as pVSV‐G‐TRPM8/VSV‐G‐TRPM8 mean ± SEM. TRPM8, transient receptor potential
melastatin type 8
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Dasatinib is also an Src kinase inhibitor, more selective compared
with PP2 (Brandvold, Steffey, Fox, & Soellner, 2012). We monitored
the effect of dasatinib, alone and in the presence of PV, on cold‐
induced calcium transients in cultured rat DRG neurons compared
with control neurons (untreated neurons and neurons treated with
PV). Cold‐induced activation of TRPM8 was inhibited by dasatinib
(Figure 6): the ratio between the amplitudes of the 2nd and 1st cold‐
induced calcium transients was 0.87 ± 0.04 (n = 31) in dasatinib‐
treated neurons compared with 1.05 ± 0.04 (n = 45) in control
conditions (two‐tailed unpaired Student’s t test, p < .01). PV completely
prevented the inhibitory effect of dasatinib (the 2nd to 1st response
ratio was 1.05 ± 0.04, n = 25, in the presence of PV, not significantly
different from control). The effect of dasatinib alone was still
significant compared with PV+dasatinib‐treated neurons for the third
cold response (the 3rd to 1st response ratio was 0.86 ± 0.06, n = 31,
for dasatinib‐treated cells, compared with 1.01 ± 0.05, n = 25, for PV
+dasatinib‐treated neurons, two‐tailed unpaired Student’s t test,
p < .05), but not significantly different from control cells (Figure 6b).
4 | DISCUSSION
Our results demonstrate that Src tyrosine kinase phosphorylates
TRPM8 and modulates the cold‐induced activation of the channel.
The amplitude of TRPM8‐mediated cold‐induced calcium transients
was reduced in the presence of the selective Src inhibitor PP2 in
F IGURE 5 Src silencing diminishes the effect of PP2 on cold‐induced calcium transients in HEK293‐hTRPM8 cells. (a) Western blot assay,
using anti‐Src, anti‐Src (phospho418) and anti‐actin antibodies, to demonstrate the protein expression and the phosphorylation of endogenous
Src kinase at tyrosine 418. Src kinase expression was reduced in Src_siRNA‐transfected cells after 96 hr, compared with control cells or
scrambled RNA‐transfected cells. (b) Relative quantification of Src protein tyrosine kinase normalized to actin or GAPDH expression in
HEK293‐hTRPM8 cells. Data are presented as ratio mean ± SEM. (c) Mean ΔF/F0 for TRPM8‐mediated cold‐induced calcium transients in four
conditions: (A) Src_siRNA‐transfected, control (red filled circles), (B) Src_siRNA‐transfected, PP2‐treated (red open circles), (C) Scrambled RNA‐
transfected, control (black filled triangles) and (D) Scrambled RNA‐transfected, PP2‐treated (black open triangles). Values represent mean ΔF/
F0 ± SEM. (d) Comparison of the ratio between the amplitudes of the 7th and the 1st cold‐induced calcium transients for the experiment
illustrated in (c). ANOVA, analysis of variance; GAPDH, glyceraldehyde 3‐phosphate dehydrogenase; TRPM8, transient receptor potential
melastatin type 8 (****p < .0001, one‐way ANOVA for independent samples)
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HEK293 cells co‐expressing human TRPM8 and a constitutively
active isoform of Src. A similar, albeit less pronounced effect was
produced by PP2 in HEK293 cells expressing just hTRPM8, indicating
that inhibition of endogenous Src is sufficient to produce functional
downregulation of the channel. Interestingly, the inhibition of TRPM8
phosphorylation by PP2 in HEK293 cells cotransfected with hTRPM8
and Src Y527F was almost complete (Figures 3d and 3e) while the
effect of PP2 on endogenous Src led to only approx. 70% inhibition of
TRPM8 phosphorylation (Figures 4d and 4e). The reason for this
difference is unclear. However, in agreement with this difference,
there was a stronger effect of PP2 on TRPM8 function in the first
case (leading to an approx. 38% reduction in response amplitude to
cold stimulation), compared with the second case (endogenous Src),
where the inhibition induced by PP2 was of approx. 25%. A stronger
reduction of TRPM8 phosphorylation was associated with a stronger
inhibition of TRPM8 function.
The cold‐induced activity of natively expressed TRPM8 in
cultured rat primary afferent neurons was also decreased by acutely
applied PP2, and a similar but less potent effect was induced by
another selective Src inhibitor, dasatinib. In both cases, the negative
modulatory action of the Src inhibitors on TRPM8 was antagonized
by PV, a protein tyrosine phosphatase inhibitor. The fact that two
different chemically unrelated Src inhibitors produce a similar effect
on TRPM8‐channel function confirms that Src inhibition is respon-
sible for this action, and not a direct antagonistic action of the two
molecules on the channel itself. This conclusion is strengthened by
two additional observations: that the effects of PP2 and dasatinib are
antagonized by PV, and that the negative modulation of recombinant
hTRPM8 by PP2 is abolished following downregulation of endogen-
ous Src by RNA interference.
c‐Src is a proto‐oncogene known for its involvement in transforma-
tion, migration, invasion, and proliferation of tumor cells. Elevated c‐Src
activity has been reported in tumors from colon, liver, breast, pancreas,
prostate, and lung (Dehm & Bonham, 2004; Nam et al., 2005). On the
other hand, increased levels of TRPM8 expression were observed in
prostate cancer, osteosarcoma, pancreatic adenocarcinoma, breast
ductal adenocarcinoma (Hantute‐Ghesquier et al., 2018), thus suggest-
ing that c‐Src and TRPM8 may play synergistic roles in the progression
F IGURE 6 PP2/dasatinib‐induced inhibition of TRPM8‐mediated calcium transients in cultured rat DRG neurons is reduced in the presence
of the PTP inhibitor PV. (a) DRG neurons were challenged with three cold ramps (from ∼32°C to ∼25°C, 45 s duration, at 5min interval),
followed by (−)‐menthol (200 μM, 30 s) and KCl (50mM, 30 s). Examples of traces from individual rat DRG neurons in control conditions
(untreated neurons), treated with PP2, with both PP2 and PV, with dasatinib and with both dasatinib and PV. (b) Statistical analysis of the
results illustrated in part (a) for the five different conditions: (A) control or PV‐treated (n = 45; black), (B) treated with PP2 only (n = 26; red), (C)
treated with both PP2 and PV (n = 21; blue), (D) treated with dasatinib only (n = 31; orange) and (E) treated with both dasatinib and PV (n = 25;
green). Values represent mean ± SEM responses normalized to the first cold ramp. DRG, dorsal root ganglion; PV, pervanadate; PTP, protein
tyrosine phosphatase; TRPM8, transient receptor potential melastatin type 8 (****p < .0001, two‐tailed unpaired Student’s t test, ***p < .001,
two‐tailed unpaired Student’s t test, **p < .01, two‐tailed unpaired Student’s t test, *p < .05, two‐tailed unpaired Student’s t test, ns p > .05,
two‐tailed unpaired Student’s t test)
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of some tumor forms. However, TRPM8 cannot be simply considered as
an oncogene. The complexity of its functional implication in cancer is
illustrated by its role in prostate cancer: while TRPM8 expression is
correlated with the transformation of malignant cells, in androgen‐
dependent prostate carcinoma it inhibits the migration of tumor cells
due to inactivation of adhesion kinase (Hantute‐Ghesquier et al., 2018).
Our results show that both Src and TrkA kinases can phosphorylate
TRPM8, but the efficiency of Src‐mediated phosphorylation seems to be
substantially higher. In addition, the almost complete fading of TRPM8
phosphorylation after 8 hr treatment with PP2 (Figure 2) suggests that
TRPM8 is tyrosine phosphorylated exclusively by a member of the Src
subfamily of kinases. However, we cannot rule out that activation of Src
kinases results from their crosstalk with TrkA. Indeed, a large number
of tyrosine kinase receptors were proved to be activators of Src and of
its oncogenic transduction pathways (Mezquita, Mezquita, Pau,
Mezquita, & Mezquita, 2014).
Our results are also relevant for the understanding of the role
played by TRPM8 in inflammatory pain. Behavioral investigation of
TRPM8‐null mutant mice revealed an important contribution of
TRPM8 to the development of cold allodynia following paw
injection of Complete Freund’s Adjuvant (CFA; Colburn et al.,
2007). However, this is not easily reconciled with the fact that
many different inflammatory mediators, such as bradykinin,
prostaglandin E2, NGF, and extracellular protons, are known to
downregulate TRPM8 function (Andersson, Chase, & Bevan, 2004;
Linte, Ciobanu, Reid, & Babes, 2007; Liu & Qin, 2005; Premkumar
et al., 2005). Interestingly, CFA‐induced inflammatory pain
appears to be dependent on the activation of c‐Src kinase (Nagae
et al., 2006), and the potentiation of TRPM8 activity upon Src‐
mediated tyrosine phosphorylation reported here may explain the
involvement of this channel in the CFA‐induced inflammatory cold
hypersensitivity.
The molecular mechanism of TRPM8 activation by cold is not
fully understood, but it has been shown that TRPM8 reconstituted
in planar lipid bilayer is gated by cold (Zakharian, Cao, & Rohacs,
2010). Thus, it was elegantly proved that TRPM8 is directly
activated by cooling, without the involvement of any external
signaling cascades. The authors also provided evidence that cold‐
driven channel openings were accompanied by substantial varia-
tions in enthalpy and entropy, indicating significant conformational
rearrangements in the protein structure. Our results, showing that
Src‐mediated phosphorylation of TRPM8 potentiates cold‐induced
activation of TRPM8, could be explained in terms of these findings:
tyrosine phosphorylation is likely to induce conformational changes
leading to increased channel activity. The tyrosine residues
potentially involved in such modifications could be located in the
C‐terminal region, given that this region was reported to be
implicated in the cold‐induced gating of TRPM8 (Brauchi, Orta,
Salazar, Rosenmann, & Latorre, 2006). Other putative tyrosine
residues involved in the modulation of TRPM8 channel activity
could be the conserved residues Tyr826 and Tyr836 situated on the
S4 transmembrane helix, according to the recently published
TRPM8 structure (Yin et al., 2018). Mutations neutralizing charged
amino acids within the S4 helix and the S4‐S5 linker region reduced
the gating charge of TRPM8 (Voets, Owsianik, Janssens, Talavera, &
Nilius, 2007). Conceivably, introducing a negatively charged
phosphate moiety on a tyrosine residue located in S4 would alter
the voltage dependence of activation. Further in‐depth studies are
needed to identify the position of the Src‐phosphorylated tyrosine
residue(s) as well as to elucidate the structural basis of TRPM8 cold‐
induced activation and its modulation by tyrosine phosphorylation.
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